Business Services Industry
Somaxon Pharmaceuticals to Present at RBC Capital Markets 2007 Healthcare Conference
Business Wire, Dec 10, 2007
SAN DIEGO -- Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) today announced that Ken Cohen, president and chief executive officer, will participate in a panel presentation at the RBC Capital Markets 2007 Healthcare Conference at the Westin New York Hotel at Times Square in New York City on Thursday, December 13, 2007, at 10:00 a.m. ET (7:00 a.m. PT).
A live webcast of the presentation will be available in the Investor Relations section of the company's website under Event Scheduler at www.somaxon.com. The webcast will be archived and accessible for at least 14 days.
About Somaxon Pharmaceuticals
Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology. Somaxon has completed four successful Phase 3 clinical trials for its lead product candidate, SILENOR[TM] (doxepin HCl) for the treatment of insomnia. The company has completed a pilot Phase 2 trial for nalmefene in smoking cessation with positive results. It has also completed a Phase 2/3 clinical trial for nalmefene for the treatment of pathological gambling that did not achieve statistical significance for the primary or secondary endpoints. The company is evaluating the results from both of these trials before making determinations regarding the future of the nalmefene program.
For more information, please visit the company's web site at www.somaxon.com.
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Content provided in partnership with
Most Recent Business Articles
- CUSTOMER WIN: BEA China Selects BMC Software to Deliver Business Service Management Platform
- SiBEAM Invigorates CE and PC Industries with Launch of Products and Partnerships to Fuel WirelessHD® Expansion
- Research and Markets: China Chocolate Market Overview 2009-2010: a Guide to Selling Chocolate in China with Full Forecasts to 2010 and Key Statistical Data
- Project Management Institute Global Accreditation Center for Project Management Education Programs Extends Agreement with China National Steering Committee of Professional Education of Masters of Engineering
- Research and Markets: China Sulfur Industry Report Reveals the Market Increased Greatly, Importing 9.72 Million Tons in the First Nine Months Alone in 2009
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- Using object-oriented analysis and design over traditional structured analysis and design
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Design a commission plan that drives sales - Sales Commissions
